Abstract
Dosimetry of iodoantipyrine labeled with radioactive iodine was determined by measuring the biodistribution of 131I-iodoantipyrine in 41 female rabbits. Following administration of the radiopharmaceutical, subjects were killed at 0.5, 6, 12, 17, 24, 36, and 48 h. Organs and samples of tissues and body fluids were assayed. Results were corrected for physical decay. Exponential functions were employed to describe the time-concentration curves; representative value would be the biological half life of 9.96±0.55 h for blood. Cumulated activity estimates for 123I, 125I and 131I were then computed. Extrapolation to absorbed dose in humans followed the formulation of the Medical International Radiation Dose (MIRD) Committee of the Society of Nuclear Medicine. The whole body absorbed doses are 7 μGray, 5 μGray and 29 μGray per MBq of 123I, 125I, and 131I administered respectively.
Similar content being viewed by others
References
Anghileri J, Recchi N, Baruel J (1966) Fate of injected 4-iodoantipyrine (131I) in rats. Experienta 22:78–80
Chu RYL, Carlile PV, Gray BA, Allen EW, Basmadjian G, Myers J (1988) Measurement of lung water which iodoantipyrine. Eur J Nucl Med 14:538–541
Chu RYL, Carlile PV, Basmadjian G (1989) Dual-isotope measurement of lung water. International Journal of Radiation Applications and Instrumentation, Part B. Nucl Med Biol 16:419–421
Critchley M, Prichard H, Grime JS, Patten M, Ansell I (1981) Radionuclide assessment of extravascular lung water in minimal pulmonary oedema. Clin Radiol 32:607–609
Dolphin GW, Eve IS (1966) Dosimetry of the gastrointestinal tract. Health Phys 12:163–172
Ekeh S (1988) Dosimetry of 4-iodoantipyrine labeled with radioactive iodine. Master of Science Thesis, University of Oklahoma, Oklahoma City
Eve IS (1966) A review of the physiology of the gastrointestinal tract in relation to radiation dose from radioactive materials. Health Phys 12:131–161
Harknes J, Wagner JE (1983) The biology and medicine of rabbits and rodents, 2nd ed. Lea and Febiger, Philadelphia, pp 8–55
Kozma C, Macklin W, Cumis LM, Manuer R (1974) Anatomy, physiology, and biochemistry of the rabbit. In: Welsbroth S, Flatt R, Kraus A (eds) The biology of the laboratory rabbit. Academic Press, Orlando, Florida, p 49
Loevinger R, Berman M (1968a) Schema for absorbed-dose calculations for biologically distributed radionuclides. MIRD Pamphlet No. 1. J Nucl Med 9:7–14
Loevinger R, Berman M (1968b) A revised schema for calculating the absorbed dose from biologically distributed radionuclides. MIRD Pamphlet No. 1. J Nucl Med 9:7–14
Oldendorf WH (1962) Measurement of the mean transit time of cerebral circulation by external detection of an intravenously injected radioisotope. J Nucl Med 3:382–398
Oldendorf WH, Kitano M (1964) The free passage of 131I antipyrine through brain as an indication of A-V shunting. Neurology 14:1078–1083
Pomentale T (1968) Minimization of a sum of squares of functions (MINSQ). CERN Computer Center, D507
Snyder WS, Ford MR, Warner GG, Watson SB (1975) “S”, absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD Pamphlet No. 11. Society of Nuclear Medicine, New York Coty
Straub WH, Flanagan DF, Aaron R, Rose JC (1964) Fate of injected radioiodinated 4-iodoantipyrine in the dog and rat. Proc Soc Exp Biol Med 116:1119–1122
Sullivan JM, Rose JC (1961) Loss of 131I tag from radioiodinated 4-iodoantipyrine after its injection in the rat. J Lab Clin Med 57:955–960
Talso PJ, Lahr TN, Spafford N, Ferenzi G, Jackson HRO (1955) Comparison of the volume of distribution of antipyrine, N-acetyl-4-amino-antipyrine, and 131I-labeled 4-iodoantipyrine in human beings. J Lab Clin Med 46:619–623
Uszler JM, Bennett LR, MacDonald NS, Mena I (1974) Radionuclide imaging of the brain with 123I-iodoantipyrine. J Nucl Med 15:540–541
Author information
Authors and Affiliations
Additional information
This work was supported by a research grant from the Veterans Administration
Rights and permissions
About this article
Cite this article
Chu, R.Y.L., Ekeh, S. & Basmadjian, G. Dosimetry of iodoantipyrine. Eur J Nucl Med 15, 796–799 (1989). https://doi.org/10.1007/BF00255499
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00255499